Home/Filings/4/0001437749-19-010054
4//SEC Filing

Latkin Jed 4

Accession 0001437749-19-010054

CIK 0000810509other

Filed

May 14, 8:00 PM ET

Accepted

May 15, 4:04 PM ET

Size

7.0 KB

Accession

0001437749-19-010054

Insider Transaction Report

Form 4
Period: 2019-05-13
Latkin Jed
Interim COO
Transactions
  • Purchase

    Common Stock

    2019-05-13$1.91/sh+2,400$4,5956,450 total
  • Purchase

    Common Stock

    2019-05-14$1.84/sh+2,000$3,6798,450 total
  • Purchase

    Common Stock

    2019-05-15$1.45/sh+1,000$1,4489,450 total

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1
  • filerCIK 0001554593

Filing Metadata

Form type
4
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:04 PM ET
Size
7.0 KB